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Abstract 
Non-pharmacological interventions have been explored in people with refractory 
chronic cough. Normally delivered by Physiotherapists and or Speech and Language 
Therapists, these interventions aim to educate patients about their cough, provide 
them with cough suppression techniques and breathing exercises, improve 
vocal/laryngeal hydration and psychoeducational counselling to help them gain 
greater control of their cough. Six key studies have been completed over the past 12 
years that have consistently found non-pharmacological interventions help to 
improve quality of life and reduce cough frequency. Some studies also found 
improvements in cough reflex sensitivity and severity. Despite promising results 
there now needs to be further work to optimise these interventions. There is a need 
to standardise terminology used such as relabelling the intervention as cough control 
therapy and move away from uni-disciplinary terms. Standardised patient selection, 
including screening protocols, optimal timing and delivery of the interventions as well 
as the outcome measures used to evaluate interventions need further exploration. 
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Abbreviations: 
ACE-I – Angiotensin converting enzyme inhibitors 
C2 – Concentration of capsaicin at which a participant cough 2 or more times 
C5 - Concentration of capsaicin at which a participant cough 5 or more times 
ENT – Ear, Nose and Throat 
GERD – Gastroesophageal reflux disease 
ILO – Inducible Laryngeal Obstruction 
LCQ – Leicester cough questionnaire 
PSALTI – Physiotherapy, Speech and Language Therapy Intervention (PSALTI) 
PVFM – Paradoxical vocal fold movement  
RCT – Randomised control trial 
SPEICH-C – Speech pathology evaluation and intervention for chronic cough 
VAS – Visual Analogue Scale 
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Introduction 
Chronic cough, defined as a cough lasting >8weeks in duration, has an estimated 
prevalence of 12% in the general population (Morice et al 2006, Ford et al 2006). 
Studies have shown repeatedly the impact of chronic cough on individuals that 
include physical, psychological and social symptoms (Brignall et al 2008, Birring et al 
2003). In patients with chronic cough with a normal chest x-ray the common causes 
of cough are asthma, gastroesophageal reflux disease (GERD) and rhinitis (Morice 
et al 2004, Morice et al 2006). However despite extensive assessments and medical 
management in up to 40% of chronic cough cases the cough persists (Haque et al 
2005). A variety of terms have been used in the literature for this patient group 
including: idiopathic chronic cough, refractory chronic cough and cough 
hypersensitivity syndrome (Patel et al 2011, Morice et al 2006, Morice et al 2014); for 
this paper we will use the term refractory chronic cough. Treatments for refractory 
chronic cough have historically largely been pharmacological interventions, some of 
which have shown promising results however many have side-effects (Chung, 2014). 
However over the past 12 years there has been a series of progressive studies that 
have investigated the role of non-pharmacological inventions for refractory chronic 
cough which have found promising results. This review will explore the components 
of non-pharmacological interventions for refractory chronic cough, the eligibility of 
refractory chronic cough patients for non-pharmacological interventions, the 
treatment effects of these interventions, as well as the proposed mechanisms of 
action and the future direction for non-pharmacological interventions for people with 
refractory chronic cough. 
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1. Non-pharmacological interventions: components 
Non-pharmacological interventions for refractory chronic cough in the literature have 
largely been delivered by either speech and language therapists or physiotherapists 
(Chamberlain et al 2014). The variation in therapist delivering these interventions in 
the literature appears to be country-dependant and may reflect the differing roles of 
these professions in these countries. However within the UK it is known clinically 
there is also variation in different NHS trusts as to whether Speech and Language 
Therapists or Physiotherapists deliver these interventions, the reasons for variations 
are unknown but could be related to service provision differences within trusts.  
The first non-pharmacological studies that were conducted were small case studies 
(all n≤5). Blager et al (1988) explored the effect of speech pathology; consisting of 
diaphragmatic breathing exercises, cough suppression and identification of cough 
trigger and additional psychotherapy on patients with psychogenic habit cough (n=4) 
and found subjectively reported improvements in cough.  Riegel et al (1995) was a 
single case study that explored the use of biofeedback therapy; consisting of EMG- 
assisted muscle relaxation, relaxed diaphragmatic breathing, ice massage for 
muscle spasm, postural advice and exercises and additional psychotherapy  which 
resulted in the patient’s self-reported reduction in cough frequency and severity. 
Murry et al (2004) explored the effect of two to six sessions of respiratory retraining 
to improve breathing pattern technique over two to six months which resulted in a 
mean reduction of cough severity of 7.9points (range 7 to 8.5 points) on cough 
severity VAS pre and post treatment. 
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Since these initial case studies there have been at least six non-pharmacological 
studies have been completed over the past 12 years, lead predominantly by two 
research groups. The first in Newcastle, Australia whose non-pharmacological 
interventions have been delivered by Speech and Language Therapists. The second 
in London, England whose service is Physiotherapy led and have investigated non-
pharmacological interventions for refractory chronic cough delivered by 
Physiotherapists solely and by Physiotherapists and Speech and Language 
therapists in a multi-centre trial within England. 
 
Due to the different professions providing non-pharmacological interventions for 
refractory chronic cough, a variety of terms have been used to name and describe 
these non-pharmacological interventions (Table 1). Chamberlain Mitchell et al (2017) 
is the only study that investigated the effects of non-pharmacological interventions 
for refractory chronic cough which was provided by Physiotherapists and Speech 
and Language Therapists. The profession delivering the intervention depended on 
the site the participants were treated at, and therefore a joint professional name was 
used to name the intervention used in this study.  
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Table 1. Different names for non-pharmacological intervention for chronic cough in 
the literature. 
Speech and Language Led 
non-pharmacological studies  
 
Physiotherapy led non-
pharmacological studies  
Speech pathology management/ 
treatment 
 Cough-suppression physiotherapy 
Speech pathology evaluation 
and intervention for chronic 
cough (SPEICH-C) 
  
Physiotherapy and Speech and Language Therapy Intervention (PSALTI) 
 
However despite the varying terms used to name these interventions the key 
treatment components of these interventions have been very similar, as seen in 
Table 2.  
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Table 2: Key components of treatment in non-pharmacological intervention studies. 
Adapted from Chamberlain et al, 2014. 
Components Vertigan 
et al 
2006 
Ryan 
et al 
2009 
Ryan 
et al 
2010 
Patel 
et al 
2011 
Vertigan 
et al 
2016 
Chamberlain 
Mitchell et al 
2017  
Education on chronic  
cough and identifying cough 
triggers 
 
√ √ √ √ √ √ 
Cough suppression 
techniques  
√ √ √ 
 
√ 
 
√ √ 
Breathing exercises √ √ √ √ √ √ 
Vocal/Laryngeal hygiene 
and hydration strategies 
√ √ √ √ √ √ 
Counselling √ √ √ √ √ √ 
Throat massage    √   
 
All of the six key studies that have explored non-pharmacological interventions for 
refractory chronic cough have included: education, cough control/suppression 
techniques, breathing exercises, vocal hygiene and hydration strategies and 
counselling (Chamberlain et al 2014, Chamberlain Mitchell et al 2017). In the 
literature these components have been summarised as four key components of non-
pharmacological interventions as the breathing exercises are included within the 
cough suppression component. Table 3 explains these four key components in more 
detail. 
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Table 3. Non-pharmacological interventions’ treatment components 
Non-
pharmacological 
component 
Technique 
Education Educate patients on cough: the anatomy of the reflex, that 
the cough reflex is both an involuntary and voluntary reflex, 
what chronic cough is and current understanding of how it 
can develop including the role of repeated irritation of vocal 
folds through repeated coughing as well as cough reflex 
hypersensitivity. 
Explain the negative effects of repeated coughing and 
throat clearing. 
Explain the aims and benefits of non-pharmacological 
interventions. 
Vocal/Laryngeal 
hygiene and 
hydration 
Increase frequency and volume of water and non-
caffeinated drinks (at least 2 litres a day) 
Reduce caffeine and alcohol intake 
Promote nasal breathing – nasal douching may be 
recommended to help nasal breathing if patient is 
congested. Nasal steam inhalation may be recommended 
to help humidification of the vocal tract. 
Cough 
control/suppression 
techniques 
Teach patients to identify their cough triggers so they are 
able to use cough suppression or distraction techniques at 
the first sign or sensation of the need or urge to cough. 
Cough suppression/distraction techniques include: 
forced/dry swallow, sipping water, chewing gum or sucking 
non-medicated sweets or lollies over a short period of time. 
Breathing pattern re-education promoting a relaxed 
abdominal breathing pattern technique whilst inhaling 
through the nose. 
May include PVFM release breathing, Cough Control 
Breathing and purse lip breathing 
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Psycho-educational 
counselling 
Behaviour modification: to try to reduce over-awareness of 
the need to cough and facilitate individuals’ internalisation 
of control over their cough.  
Motivate patients, reiterate the techniques and the aims of 
therapy 
Stress and anxiety management 
Modified from Chamberlain Mitchell et al 2017 
 
Education is a very important component of non-pharmacological interventions. 
Patients need to understand what the cough reflex is, how chronic cough can 
develop and the negative effects of repeated coughing, as well as that the cough 
reflex is both an involuntary and voluntary reflex. Emphasising these aspects will 
help patients understand the aims of non-pharmacological interventions. Non-
pharmacological interventions aim to increase patients’ control of their cough, giving 
them techniques to help them suppress their cough, which over time is hoped will 
help to reduce their cough reflex sensitivity as well as reduce localised irritation that 
initiates the cough (Chamberlain Mitchell et al 2017, Vertigan et al 2006, Vertigan 
and Gibson 2016). 
The vocal/laryngeal hygiene and hydration techniques aim to improve vocal tract 
hydration as dryness of the vocal tract is a prevalent throat symptom in refractory 
chronic cough, which can increase laryngeal irritation and initiate cough. All of the six 
key studies for non-pharmacological interventions have included advice on 
increasing hydration and promoting nasal breathing. However, only Chamberlain 
Mitchell et al (2017) included the option of recommending nasal douching for 
patients who struggle to breathe nasally.  The cough control/suppression techniques 
aim to equip the patients with strategies to use when they first feel an urge to cough 
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to try to suppress their cough early. Although all the studies have included cough 
control/suppression techniques whether they advised chewing gum or sucking 
medicated lollies or sweets has varied between the studies (Chamberlain Mitchell et 
al 2017, Vertigan et al 2006, Vertigan and Gibson 2016).   
All the studies in Table 2 have included breathing exercises, however the exercises 
included as well as the terminology for the exercises varies between the studies. 
Limited detail is provided in Vertigan et al (2006), Ryan et al (2009) and Ryan et al 
(2010) studies regarding the breathing exercises apart from that relaxed throat 
breathing was used for patients with inspiratory dyspnoea. Vertigan and Gibson 
(2016) provided more detail on the breathing exercises included and describes the 
techniques as PVFM release breathing and Cough Control Breathing. PVFM release 
breathing is a technique that encourages patients to practice a relaxed abdominal 
breathing pattern technique, working to reduce upper body, shoulder and neck 
tension, inhaling through pursed lips, via their nose or via a sniff and exhaling 
through pursed lips with their mouth relaxed (Vertigan and Gibson 2016). Cough 
Control Breathing is a technique taught to patients to be used to interrupt/prevent 
their cough when they feel an urge to cough, they are required to breathe in through 
their nose and blow out quickly through pursed lips, the technique can be altered so 
participants can also sniff prior to breathing out through tight lips (Vertigan and 
Gibson 2016). Patel et al (2011) and Chamberlain Mitchell et al (2017) included 
similar breathing exercises but with some variation and different terminology for the 
exercises. The breathing exercises were labelled as breathing pattern re-education 
during which patients were encouraged to breathe through their nose and out 
through their mouth focusing on a relaxed abdominal breathing pattern technique, 
however they were not required to breath out through pursed lips or inhale via a sniff 
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(Patel et al 2011; Chamberlain Mitchell et al 2017). In addition both studies included 
a technique called pursed lip breathing for which participants were instructed to 
inhale via their nose and exhale gently through pursed lips, so the technique was 
less forceful than cough control breathing described above (Patel et al 2011; 
Chamberlain Mitchell et al 2017). Again these variations in techniques used highlight 
the differences used by Speech and Language Therapists and Physiotherapists. 
The psychoeducational counselling component of the treatment aims to motivate 
patients to continue to engage in the treatment and techniques taught, reinforcing to 
patients that techniques take time to master for them to notice a difference 
(Chamberlain Mitchell et al 2017, Vertigan and Gibson 2016).  
For our PSALTI study we also included stress and anxiety management within this 
component which explains to patients the effect of over awareness of sensations and 
the need to try and change their thoughts about managing their cough to help 
facilitate individuals’ internalisation of control over their cough and reinforce to 
patients that their cough isn’t a phenomenon outside of their control (Chamberlain 
Mitchell et al 2017). 
Patel et al (2011) is the only study that has included throat massage as an additional 
treatment for patients with muscle tension from excessive coughing.  
Eligibility of patients for non-pharmacological interventions for refractory 
cough 
Within the six key non-pharmacological interventional studies these treatments have 
only been studied in patients with refractory chronic cough, who have undergone 
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extensive medical assessment and treatment for the main causes of cough, as seen 
in Figure 1.  
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  Vertigan et 
al 2006 
Ryan 
et al 
2009 
Ryan 
et al 
2010 
Patel 
et al 
2011 
Vertigan et 
al 2016 
Chamberlain 
Mitchell et al 
2017  
In
c
lu
s
io
n
 c
ri
te
ri
a
 
Age>18 years old √ √ √ √ √ √ 
Age <80 years old  √ √  √  
Treatment and assessment for 
asthma, postnasal drip syndrome, 
gastro-oesophageal reflux and 
withdrawal of ACE-I 
√ √ √ √ √ √ 
Hypertonic saline challenge √ √     
Induced sputum analysis √ √ 
  
  
Non-smokers 
 
√ √ √ √ √ 
Ex-smokers< 10 pack year  √ √    
Normal chest X-ray √ √ √ √  √ 
No respiratory disease √ √ √  √ √ 
No cardiac disease  √ √    
Minimal sputum production (<10ml per 
day) 
     √ 
 PVFM confirmed by laryngoscopy  √     
E
x
c
lu
s
io
n
 C
ri
te
ri
a
 
Upper respiratory tract infection √ 
  
√ √ √ 
Untreated allergy √      
Eosinophilic bronchitis √      
Neurological voice disorder √      
Significant change in cough severity in 
past 4 weeks 
   √   
Abnormal lung function tests    √   
Vocal cord nodules or malignancy      √ 
Active aspiration      √ 
Cough productive of mucopurulent 
sputum 
    √  
Pregnancy/ breastfeeding     √  
Significant psychiatric or neurologic 
disorder 
    √  
Previous Speech pathology treatment 
for cough in past 12 months 
    √  
ACE-I angiotensin converting enzyme inhibitors, PVFM paradoxical vocal fold movement 
Figure 1 Inclusion and Exclusion criteria for non-pharmacological interventions 
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Despite the participants groups within non-pharmacological interventions initially 
appearing similar as all have described the populations included as refractory 
chronic cough patients. Figure 1 highlights the variation in the population groups. A 
standardised inclusion/exclusion criteria for these interventions has yet to be 
developed. 
2. Treatment effects of non-pharmacological interventions 
Non-pharmacological interventions have consistently been found to improve cough 
related quality of life (Table 4). The PSALTI study has been the only study to explore 
cough related quality of life in a Randomised Control Trial (RCT) comparing a non-
pharmacological intervention with a control intervention of healthy lifestyle advice 
and education and found the improvement in quality of life to be significantly greater 
in the intervention group. The mean improvement in cough related quality of life was 
also greater than the minimally clinically important difference for Leicester Cough 
Questionnaire (LCQ).  
In the studies that have investigated the effects of non-pharmacological interventions 
on cough frequency, all have found the interventions to significantly reduce cough 
frequency. Chamberlain Mitchell et al (2017) study was the only study to investigate 
cough frequency in a RCT compared to a control intervention and found a significant 
reduction in the intervention group compared to the control. 
Less conclusive and consistent results have been found for cough severity 
(measured with symptom scales) and cough reflex sensitivity. Vertigan et al (2006) 
found a significantly greater improvement in patient rated cough severity score in the 
intervention group than the control group. Vertigan et al (2016) also found a 
significant reduction in cough severity for both the speech pathology and placebo 
Page 16 of 37 
 
medication group and the speech pathology and Pregablin group but there was no 
control group (received no non-pharmacological intervention) for comparison. In 
Chamberlain Mitchell et al’s (2017) study a significant within group reduction in 
cough severity VAS was only found in the PSALTI group but there was no significant 
between group difference. This may be due to an insufficient sample size for the 
VAS outcome measure in the Chamberlain Mitchell et al (2017) study.  
Ryan et al (2009), Ryan et al (2010) and Vertigan et al (2016) all found significant 
improvements in cough reflex sensitivity for their non-pharmacological interventions 
however again these were not replicated in Chamberlain Mitchell et al (2017) which 
was the only study that included a control group (received no non-pharmacological 
intervention) for comparison. The reasons for these different results found between 
studies is not clear. It may be due to the Ryan and Vertigan studies being conducted 
over a longer time period however Ryan et al (2010) found significant improvements 
in capsaicin cough challenge even after 1 session of therapy. A potential problem 
with C2 and C5 capsaicin cough reflex sensitivity testing in patients, who have 
received non-pharmacological interventions for their cough, is that during their 
treatment they have been taught cough suppression techniques and repeatedly 
encouraged by their therapist to actively suppress their cough. This may then affect 
the results of C2, C5 capsaicin cough testing as although instructed to ‘‘allow 
yourself to cough if you need to, and as much as you need to’, some participants 
may not and there may be variation in how strictly individual patients follow this 
instruction especially having received cough suppression techniques. Instead 
previously used measures of cough suppression may be more appropriate such as 
Hutchings et al (1993) and Cho et al (2017) whereby the participants received 
increasing dosages of capsaicin and were instructed to try to not cough. This would 
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give an idea of the patients’ ability to suppress their cough which may be a more 
appropriate outcome measure as it would give greater insight into the effectiveness 
of their cough suppression ability post intervention.  
Vertigan et al (2016) is an interesting study as it is the only study that has explored 
speech pathology treatment in combination with antitussive medication.  In this trial 
both groups received speech pathology treatment, but one group received Pregablin 
in addition. It was hoped that combining speech pathology with Pregablin would 
result in better cough outcome improvements as well sustained improvement after 
the discontinuation of Pregablin. For cough related quality of life and cough severity 
a greater improvement was found for speech pathology and Pregablin then speech 
pathology and placebo medication. 
Page 18 of 37 
 
Table 4. Treatment effects of non-pharmacological interventions  
 Study 
Design and 
participant 
numbers 
Frequency and 
length of treatment 
sessions 
Outcome measures* Results Limitations 
Vertigan et 
al 2006 
RCT 
n=87 
participants(
43 in 
treatment 
group and 
44 in 
placebo 
group) 
4 x 30minute 
sessions over a 2 
month period with a 
Speech and 
Language 
Therapist. 
SPEICH-C received 
intervention as 
described earlier. 
Placebo group 
received healthy 
lifestyle advice. 
Patient rated subjective 
symptom severity scores on a 
5 point Likert scale covering 
cough, respiratory, voice and 
upper airway symptoms 
Limitations of symptoms on 
everyday activity were also 
rated on a 5 point Likert scale 
Treating speech pathologist 
rated post participant’s 
outcome as successful, 
partially successful or 
unsuccessful. 
Significant improvement in cough scores for Rx 
group (95% CI 3 to 4.9; p<0.001) and placebo 
groups (95% CI 0.3 to2.2; p<0.001). 
However improvement was significantly greater in 
Rx group (95% CI 1.3 to 4.0; p<0.001) 
Significant improvements in total symptom score 
(95% CI 9.0 to 16.1; p<0.001) and limitation to daily 
activities (95% CI 0.4 to 1.0; p<0.001) in treatment 
group only. 
88% reported as having a successful outcome in 
the treatment group compared to only 14% in the 
control treatment. 
No Objective 
outcome 
measures 
used 
Ryan et al 
2009 
Uncontrolled 
trial 
n=14 
received 
speech 
pathology 
treatment 
4 weekly sessions 
with a Speech and 
Language 
Therapist 
Cough-related quality of life: 
LCQ at baseline and at follow 
up. 
Generic Quality of life 
measure: SF-36 at baseline 
and at follow up. 
Cough reflex sensitivity: 
Capsaicin cough challenge 
performed at baseline. 
Cough related quality of life significantly improved 
(LCQ P=0.001) post treatment. 
Cough reflex sensitivity significantly improvement 
(C5 p=0.008) post treatment. 
No information given in article regarding sf-36 
scores or changes. 
 
 
Uncontrolled 
trial 
Small sample 
size 
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Ryan et al 
2010 
Uncontrolled 
trial 
n=17 
 
Up to 4 treatment 
sessions with a 
Speech and 
Language 
Therapist (baseline 
visit, 4 treatment 
visits and post 
treatment visit were 
over 14 to 18 week 
period) 
Cough Frequency: ~1 hour 
Leicester Cough monitor 
performed at each session and 
at follow up 
Cough reflex sensitivity: 
Capsaicin cough challenge 
performed at each session and 
follow up. 
Cough-related quality of life: 
LCQ at baseline and follow up. 
Significant decrease in cough frequency post 
treatment (p=0.009). Significance of difference was 
only reached after treatment 3 and continued to 
decrease at treatment session 4 and post treatment 
session. 
Cough reflex sensitivity significantly decreased post 
treatment (mean  SD log C5, 1.65  0.88, 
p<0.0001). Cough threshold and urge to cough also 
significantly improved post treatment (p=0.001; 
p=0.01 respectively). Cough reflex sensitivity 
significantly reduced after each session. 
Significant improvement in cough-related quality of 
life (p=0.002) post treatment. 
Uncontrolled 
trial 
Small sample 
size 
 
Cough 
monitor only 
used for 1 
hour which is 
less than the 
validated time 
for Leicester 
cough 
monitor (Lee 
et al, 2012)  
Patel et al 
2011 
Uncontrolled 
trial 
n=23 
Up to 3 weekly 
treatment sessions 
with a 
Physiotherapist. 
Post treatment 
assessment 
completed 2 
months after 
treatment 
Cough-related quality of life: 
LCQ measured at baseline 
and 2 month follow up. 
Cough frequency was 
measured with a 7 point Likert 
scale. 
Cough related quality of life significantly improved 
(mean difference 2.7, 95% confidence interval of 
difference -4.1, -1.3; p<0.001). In all the three 
domains of the LCQ, physical (p=0.001), 
psychological (p<0.001) and social (p<0.04) 
Significant reduction in reported cough frequency 
(Mean difference 1.1; 95% confidence interval of 
difference 0.5-1.8; p=0.002). 
Uncontrolled 
trial 
Small sample 
size 
No objective 
outcome 
measures 
 
Vertigan et 
al 2016 
RCT 
n= 40 ( 20 
participants 
received 
All participants 
received 5 speech 
pathology treatment 
sessions over a 14 
Cough-related quality of life as 
measured by Leicester cough 
questionnaire 
Cough severity measured by 
Cough related quality of life improved significantly in 
both groups (geometric mean difference (SD) 
SP+Preg 6.6 (4.5) vs SP+Plac 3.3 (2.3). 
Significantly greater improvement in SP+Preg ( 
Lack of long 
term follow 
up. 
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speech 
pathology 
and 
placebo, 20 
participants 
received 
speech 
pathology 
and 
Pregablin) 
week period 
The speech 
pathology and 
Pregablin group in 
addition received 
Pregablin (max 
dose 300mg/day) 
for 14 weeks 
The speech 
pathology and 
placebo group 
received placebo 
tablet for 14 weeks 
Follow up outcome 
measures 
completed 4 weeks 
post treatment 
cough visual analogue scale 
(VAS) 
24 hour cough frequency 
measured by Leicester cough 
Monitor 
Cough reflex sensitivity 
measured by Capsaicin cough 
challenge (c5 end point) 
Urge to cough measured by 
urge to cough scale at end of 
cough reflex sensitivity testing 
(c5) 
 
 
mean difference (SD) 3.5 (1.2), p=0.024) 
Cough severity decreased in both groups 
(geometric mean difference (SD) SP+Preg 38.8 
(23.4) vs SP+Plac 14.5 (20.1). Significantly greater 
improvement in SP+Preg ( mean difference (SD) 
25.1 (7.1), p=0.02). 
Cough frequency significantly decreased in both 
groups (geometric mean difference (SD) SP+Preg 
11.2 (18.3) vs SP+Plac 8.9 (18.1). No significant 
difference between the groups (p=0.671). 
Cough reflex sensitivity significantly decreased in 
both groups (mean difference (SD) SP+Preg 136.3 
(230.6) vs SP+Plac 89.3 (176.8). No significant 
difference between the groups (p=0.362). 
Urge to cough at C5 significantly decreased in both 
groups (mean difference (SD) SP+Preg 2.0 (2.8) vs 
SP+Plac 3.1 (3.0). No significant difference 
between the groups (p=0.949). 
Chamberlain 
Mitchell et al 
2017 
Multi-
centred 
RCT 
n=66 
completed 
treatment at 
4 weeks (26 
completed 
PSALTI 
treatment, 
37 
4 weekly treatment 
sessions with either 
a Physiotherapist or 
with a Speech and 
Language 
Therapist 
PSALTI group 
received 
intervention as 
described earlier 
Primary outcome: Cough-
related quality of life as 
measured by Leicester cough 
questionnaire 
Cough severity in past two 
weeks measured by cough 
visual analogue scale (VAS) 
Objective 24 hour cough 
frequency measured by 
Cough related quality of life improved mean 1.53 
(95% CI 0.21 to 2.85) units more in PSALTI group 
then control, p=0.024. However both groups did 
improve significantly (mean difference (95%CI) 
PSALTI 3.40 (2.26 to 4.55) p<0.001, control 1.66 
(0.78 to 2.54) p<0.001). No between group 
difference was observed between 
centres/profession delivering the intervention. LCQ 
improvements were sustained at 3 month follow up. 
Cough severity decreased significantly in both 
groups (mean difference (95%CI) PSALTI -21.18 (-
Attrition rate 
however 
intention to 
treat analysis 
was 
performed in 
mitigation. 
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completed 
control 
intervention. 
 
Control group 
include healthy 
lifestyle and 
education 
Leicester cough Monitor 
Cough reflex sensitivity 
measured by Capsaicin cough 
challenge (C2 and C5 end 
point) 
Urge to cough measured by 
urge to cough scale at end of 
cough reflex sensitivity testing 
(c5) 
Generic Quality of life 
measure: SF-36 at baseline 
and at follow up. 
29.83 to -12.53) p<0.001, control -11.84 (-20.11 to -
3.57) p=0.007) However there was no significant 
between group difference (p=0.084). 
Cough frequency improved by a mean 41% (95%CI 
36% to 95%) more in the PSALTI group compared 
to the control group, p=0.030. Within group cough 
frequency only significantly improved in the PSALTI 
group (fold change (95%CI) 0.55 (0.33 to 0.75), 
p=0.002. Cough frequency improvements were 
sustained at 3 month follow up. 
Cough reflex sensitivity only significantly decreased 
for C5 in the PSALTI group (fold change (95%CI) 
1.24 (1.02 to 1.50), p=0.035.  However there were 
no significant difference between the groups for C2 
or C5 (p=0.575 and p=0.512 respectively). 
No significant between or within group changes 
were found for SF-36. 
RCT randomised control trial, NCS non-comparative study, C2 concentration of capsaicin at which the participant coughs 2 or more times, C5 concentration of capsaicin at which the participant 
coughs 5 or more times, PSALTI – Physiotherapy, Speech and Language Therapy Intervention, SPEICH-C – Speech Pathology evaluation and intervention for chronic cough. 
*Only cough related outcome measures have been included. Modified from Chamberlain et al (2014) 
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3. Mechanisms of action of non-pharmacological interventions 
There is still quite a debate as to the potential mechanisms of action of non-
pharmacological interventions for refractory chronic cough. Patients with refractory 
chronic cough have been shown to have increased peripheral and central 
sensitisation of the cough reflex as well as decreased descending inhibitory control 
of their cough (Ando et al 2016, McGovern et al 2017, Mazzone and Undem 2016). 
As a result of the increased peripheral and central sensitisation of the cough reflex 
refractory chronic cough patients suffer with hypertussia; increased sensitivity to 
tussive triggers, such as chilli and smoke; as well as allotussia, an increased 
sensitivity to non-tussive triggers, such as  talking, laughing and changes in air 
temperature (Vertigan and Gibson., 2011).   Studies have shown that patients with 
refractory chronic cough have lower thresholds before both a sensory response, “the 
urge to cough” is reported, and motor response in the form of a cough is triggered 
(Mazzone et al 2011). 
Ryan et al (2009) and Ryan et al (2010) found non-pharmacological interventions 
increase the concentration of capsaicin people with refractory chronic cough are able 
to tolerate before reporting an urge to cough. Chamberlain Mitchell et al (2015) found 
similar findings in a subset of our study population for whom urge to cough was 
explored. Therefore non-pharmacological interventions may help to re-
adjust/normalise the hypersensitive cough reflex observed in refractory chronic 
cough to at least effect the sensory response to the reflex. Whether non-
pharmacological interventions affect the cough reflex motor response is less 
conclusive at present as this has not be replicated in all studies that have 
investigated this and needs to be explored further, potentially including a change in 
the current outcomes we use to measure this as previously discussed. 
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The higher brain centers are involved in the cough reflex as well and is where the 
airway sensory nerve inputs are processed and either a cough is generated or 
suppressed (Mazzone and Undem, 2016). Non-pharmacological interventions for 
refractory chronic cough may improve patients’ cough by improving descending 
inhibitory control, affecting cognitive behavior and therefore stimulating higher brain 
center’s processing of the sensory nerve inputs from the cough reflex. During the 
education and psycho-educational counselling components of non-pharmacological 
interventions it is hoped patients’ understanding of their condition improves, as well 
as their understanding of the aims of the interventions, the harmful effects of 
repeated coughing and the need for them to actively and repeatedly work to 
suppress their cough. Chamberlain Mitchell et al (2017) also included anxiety 
management and discussion of over awareness of sensations which may have also 
helped with this. 
Another potential mechanism of action for these non-pharmacological interventions 
is treating conditions associated with refractory chronic cough. Up to 40% of 
refractory chronic cough patients have been found to have PVFM now termed 
Inducible Laryngeal Obstruction (ILO), (Vertigan et al 2007, Vertigan and Gibson 
2011). Some of the techniques used within the non-pharmacological interventions 
are also used to treat ILO. In addition Chamberlain Mitchell et al (2017) found that 
51% of our refractory chronic cough patients have dysfunctional breathing which 
again is treated using the breathing exercises included as part of PSALTI study 
(Chamberlain Mitchell et al 2016a). Interestingly when Chamberlain Mitchell et al 
(2016a) explored whether there was a difference in the response to PSALTI 
treatment for those who had breathing dysfunction or not, significant improvements 
in cough related quality of life, cough frequency and cough severity were only 
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observed in those who had breathing dysfunction prior to treatment which was 
corrected post treatment compared to those who had no change in their breathing 
pattern. However this was observed in a small subset of patients so needs further 
exploration. Figure 2 shows a schematic of the above. 
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Figure 2a. Normal Cough reflex Figure 2b. Refractory chronic Cough reflex 
Figure 2c. Non-pharmacological intervention mechanisms 
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Figure 2a shows a schematic of a normal cough reflex network. Figure 2b shows the changes that occur in the normal cough reflex network in refractory 
chronic cough. In refractory chronic cough there is an increase in sensory afferent input due to peripheral sensitisation, which leads to increased central 
sensitisation which in combination with a decreased descending inhibitory control causes an increase in efferent output (cough). It is possible that in certain 
cases of refractory chronic cough the sensory afferent input to the brain stem may reduce but the plastic changes (increased central sensitisation) in the 
central nervous system are sustained. Figure 2c shows the changes that are hypothesised to occur to the refractory chronic cough reflex as a result of 
nonpharmacological interventions. It is hypothesised that elements of the nonpharmacological interventions such as avoiding cough triggers initially and 
vocal hygiene and hydration as well as breathing techniques which may help to treat underlying conditions (such as breathing pattern disorder or inducible 
laryngeal obstruction) may reduce the sensory afferent input due to a reduction in irritation and stimulation of the cough reflex; helping to reduce the 
peripheral and central sensitisation. The education, psychoeducational counselling and cough suppression technique components of the non-
pharmacological interventions are hypothesised to help increase the descending inhibitory control.  Thus resulting in a decrease in efferent output (cough). 
Overtime it is hoped and in an ideal world the cough reflex may return to normal. 
Page 27 of 37 
 
4. The future of non-pharmacological interventions 
This review has highlighted that non-pharmacological interventions for patients with 
refractory chronic cough have shown promising results, however it has also 
highlighted a number of areas within the research of these interventions that need to 
be improved and further developed in the future.  
Patient selection 
This review has highlighted that in the six key studies of non-pharmacological 
interventions, there is large variation in the inclusion/exclusion criteria of these 
studies. This then makes it difficult when translating these research findings into 
clinical practice and trying to develop a clinical care pathway for refractory chronic 
cough patients. In addition it reinforces the heterogeneity of refractory chronic cough. 
Future research studies need to explore within the patient group of refractory chronic 
cough who is most appropriate for non-pharmacological interventions. Does there 
need to be an upper age limit of participants as seen in some studies. Age is unlikely 
to have an effect on treatment but other factors such as ability to follow instructions 
are more relevant and has not been studied. Does smoking history affect the 
outcome of treatment, is there a reason to exclude ex-smoker. As well as 
establishing what investigations and screening processes need to be completed prior 
to referring patients to non-pharmacological treatment for their cough, there is 
variation in screening tests in the literature and clinically. Laryngoscopy has not 
always been performed prior to non-pharmacological interventions for refractory 
chronic cough in the research or clinical setting and there is ongoing debate about 
this. Laryngoscopy/ Ear Nose and Throat (ENT) review may be important to rule out 
other medical reasons for the refractory chronic cough e.g. GERD, nasal disease or 
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voice disorder.  Laryngoscopy with provocation challenge is also required to 
diagnose ILO and some clinicians argue by giving visual feedback after 
laryngoscopy to patients it helps to educate patients about their ILO and/ or cough 
hypersensitivity diagnosis. Some clinicians argue that the diagnosis of ILO is needed 
so that additional specific breathing techniques can be given alongside treatment for 
the chronic cough. However having said this ILO was not screened for and 
diagnosed in all the six key studies included in this review and in those that did 
include screening for ILO the non-pharmacological interventions delivered were the 
same as in studies that did not screen for ILO and beneficial results were still found. 
More research is therefore needed to resolve these complex issues of the benefits of 
ILO diagnosis in chronic cough patients and whether there is a need for differences 
in the management of these patients or not.  
 
None of the key studies included in this review screened for evidence of breathing 
dysfunction. However Chamberlain Mitchell et al (2017) found that there may be 
differences in responses to non-pharmacological interventions in those with 
refractory chronic cough and breathing dysfunction than in those without breathing 
dysfunction however this needs further exploration. In the future if these additional 
screens are felt to be required refractory chronic cough treatment delivery may 
become more multidisciplinary and similar to breathlessness management clinics 
where patients are initially assessed by a multi-disciplinary team. The difficulty with 
assessing breathing pattern technique is that there currently is no gold standard 
measure (Boulding et al, 2016). Clinically respiratory Physiotherapists assess 
breathing pattern based on observation as part of their assessment. In the research 
literature there have been studies exploring different devices to measure breathing 
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pattern which are either remote from the patient or attached to the patient such as 
structured light pleythsmography, respiratory inductance pleythsmography and 
respiratory movement measurement instrument (RRIM) (Niérat et al, 2017; Tehrany 
et al, 2018; Olsén et al 2010). Others have also explored easier to use, less costly 
and technologically dependent measures of breathing pattern such as the Brompton 
breathing pattern assessment tool (BPAT) which provides an interval scale and 
structured format to the traditional respiratory Physiotherapy assessment (Todd et al 
2018); or Manual assessment respiratory motion (MARM) which requires the 
therapist to judge the thoracic and abdominal movement occurring through palpation 
(Courtney et al 2008). Therefore more research is needed to explore these 
techniques of measuring breathing pattern to establish a gold standard that can be 
used in future studies. 
As this review highlights these non-pharmacological interventions have only been 
investigated in people with refractory chronic cough, however are there other patient 
groups who share similar cough presentations that these interventions could be 
effective for, such as idiopathic pulmonary fibrosis and sarcoidosis. There is now 
some emerging preliminary evidence that this may be the case (Mohammed et al, 
2018). 
 
Standardisation of terminology  
Table 1 highlighted the variation in terminology used to label these non-
pharmacological interventions. Currently this is a hindrance to the promotion of these 
interventions as at first they may appear more heterogenous in the components of 
treatment then they are. In the future it would be an improvement if a standardised 
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non-disciplinary term was used to label these non-pharmacological interventions 
such as cough control therapy. This would enable future research and clinical 
studies to be labelled using the same term, it is also an easy to understand name for 
patients and explains exactly what the treatment aims to achieve. In addition a non-
disciplinary label helps both physiotherapists and speech and language therapists 
evidence their involvement with these patients as we know there is variation as to 
the profession delivering these interventions between different trusts in the UK and 
between different countries. 
 
Standardisation of treatments  
Despite the similarity of treatment components across the six key studies included in 
this review. There is variation in some of the techniques used in the studies such as 
throat massage, breathing exercises and which cough suppression techniques are 
included. The effects of these differences have not been explored. The greatest 
variation between the treatments in the six key studies is the frequency and duration. 
This again makes it hard for translation of these treatments in clinical practice. 
Variation in the studies included in this review in number of treatments has been 
between 3 to 4 sessions, received from weekly to over a 14 to 18 week period. There 
is also variation in delivery of non-pharmacological interventions in clinical practice. 
Timing of non-pharmacological interventions  
Currently clinically and in the literature non-pharmacological interventions are used 
as a last resort or when all other pharmacological interventions have been 
exhausted. Not only does this review highlight the beneficial effects of non-
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pharmacological interventions for chronic cough but these interventions have been 
found to be cheaper than some antitussive medication. The cost of PSALTI was 
£323.17 per patient compared to £471.42 for gabapentin (1800 mg dose per day and 
3 out-patient clinic visits for initiation and supervision), an antitussive used for 
PSALTI (4 outpatient sessions), (Birring et al 2017). In addition none of the studies 
included in this review have reported any adverse events from treatment.  Therefore 
the delivery of non-pharmacological intervention earlier in the patients’ treatments 
needs to be explored. This may provide even better outcomes for the treatments as 
it would reduce the cough duration prior to treatment.  
Future research also needs to explore the effects of combining cough control 
therapies with pharmacological interventions as Vertigan et al (2016) did with 
Pregablin. There are a number of emerging pharmacological treatments for cough 
such as inhibitors of the P2X3 sensory nerve ion channel which be interesting to 
explore whether non-pharmacological interventions enhanced their effectiveness. 
Outcome measures used 
Table 4 highlights the variation that has been used in the cough outcome measures 
used in non-pharmacological studies for refractory chronic cough. However in the 
more recent studies there has been an increase in the objective cough outcome 
measures used and this needs to continue. As well as continuing to use validated 
objective cough outcome measures in these studies, the outcome measures used 
may need to be reviewed. As previously discussed capsaicin cough challenge with 
C2 and C5 may not be the most appropriate measure to use to measure change in 
cough reflex sensitivity in this patient group having received cough control therapy. 
Instead previously used measures of cough suppression may be more appropriate 
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such as Hutchings et al (1993) and Cho et al (2017) whereby the participant receives 
increasing dosages of capsaicin and are instructed to try to not cough.  
Treatment delivery 
In other respiratory conditions such as asthma there has been research into the 
delivery of face to face treatments such as breathing retraining and comparing it to 
the intervention being delivered in a DVD with a printed booklet and similar 
improvements have been found in both groups compared to standard care (Bruton et 
al 2018). This as yet has not been replicated for non-pharmacological interventions 
for people with refractory chronic cough however interestingly Kapela et al (2019)) 
compared the use of pre-recorded supplemental videos of non-pharmacological 
techniques with face to face treatment to face to face treatment alone and found no 
additional significant improvement in either group.  
Others have started to explore the use of group classes instead of individual classes 
and found group classes to be beneficial however as yet these have only been 
presented as abstracts at conferences and there have been no comparative studies 
of classes versus individual treatment (Selby et al, 2017; Selby et al 2018). 
Interestingly Chamberlain Mitchell et al (2016b) found that when they asked their 
participants who had completed the PSALTI intervention at 3 month follow up which 
was 1 to 1 sessions in their trial whether they would have preferred group sessions 
rather than 1 to 1 79% of those asked reported no. 
Further studies are needed to explore treatment delivery of non-pharmacological 
interventions. 
5. Conclusion 
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Non-pharmacological interventions for refractory chronic cough have consistently 
been shown to improve quality of life and reduce cough frequency. There is a need 
for standardisation of these therapies and a change in terminology to cough control 
therapy may also help and to encourage a multi-disciplinary approach to therapy.  
Future studies need to explore patient selection for these treatments, standardisation 
of treatments included, timings of these interventions as well as outcome measures 
used. 
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